SCHEMBL1017877

SCHEMBL1017877

O=C(O)c1ccc(S)cc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.63
CASP1 P29466 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
ALDH1A1 P00352 4/20 0.50
MYC P01106 1/20 0.49
NR4A1 P22736 1/20 0.49
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.42
SRD5A2 P31213 1/20 0.42
XDH P47989 1/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
AKR1C2 P52895 2/20 0.41
AKR1C1 Q04828 2/20 0.41
TRPV4 Q9HBA0 1/20 0.41
AKR1C4 P17516 1/20 0.41
AKR1C3 P42330 1/20 0.41
MAPT P10636 3/20 0.40
KDM4E B2RXH2 2/20 0.40
CA12 O43570 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10507474 0.83 ALDH1A1 (0.63) TSHRCASP1SMN1; SMN2ALDH1A1TP53
SCHEMBL1431441 0.79 ALDH1A1 (0.48) TSHRCASP1SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL1128472 0.79 SRD5A2 (0.51) CASP1ALDH1A1NR4A1TP53CYP1A2
SCHEMBL2911184 0.78 TSHR (0.63) TSHRCASP1SMN1; SMN2ALDH1A1MYC
SCHEMBL2770320 0.77 TSHR (0.68) TSHRCASP1SMN1; SMN2ALDH1A1MYC
SCHEMBL111279 0.77 TSHR (1.00) TSHRCASP1SMN1; SMN2ALDH1A1MYC
SCHEMBL27793256 0.77 ALDH1A1 (0.46) TSHRCASP1SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL1015578 0.76 ABL1 (0.50) TSHRCASP1SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL9174867 0.76 ALDH1A1 (0.55) CASP1ALDH1A1CYP1A2MAPTKDM4E
SCHEMBL2415209 0.76 ALDH1A1 (0.61) TSHRSMN1; SMN2ALDH1A1MYCCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3859804-B1 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS CANON KK (JP) 2024-08-07 EP claimed
US-4826888-A STORAGE STABLE, DISCOLORATION INHIBITION MITSUBISHI RAYON CO., LTD. (JP) 1989-05-02 US claimed
US-12245446-B2 Semiconductor device having quantum dots, display device, imaging system, and moving body CANON KABUSHIKI KAISHA (JP) 2025-03-04 US disclosed
EP-3859804-B1 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS CANON KK (JP) 2024-08-07 EP disclosed
US-20240116872-A1 PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2024-04-11 US disclosed
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2023-08-24 US disclosed
CN-113285024-A Semiconductor device having quantum dots, display device, imaging system, and moving object 佳能株式会社 2021-08-20 CN disclosed
US-20210242416-A1 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS, DISPLAY DEVICE, IMAGING SYSTEM, AND MOVING BODY CANON KABUSHIKI KAISHA (JP) 2021-08-05 US disclosed
EP-3859804-A2 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS CANON KABUSHIKI KAISHA (JP) 2021-08-04 EP disclosed
US-20210070707-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2021-03-11 US disclosed
US-10894775-B2 Piperidine derivatives as liver X receptor beta agonists, compositions, and their use MERCK SHARP & DOHME CORP. (US) 2021-01-19 US disclosed
EP-1789390-A2 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING Genentech, Inc. (US) 2007-05-30 EP disclosed
US-20060063779-A1 Pyridyl inhibitors of hedgehog signalling CURIS ROYALTY LLC 2006-03-23 US disclosed
WO-2006028958-A2 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2006-03-16 WO disclosed
WO-2001056982-A1 VITAMIN D-DERIVATIVES AND THEIR USE IN TREATING OSTEOPOROSIS AND RELATED BONE DISORDERS LEO PHARMA A/S (DK) 2001-08-09 WO disclosed
US-5047442-A Photopolymerizable composition based on a vinyl compound, a sulfur-containing compound and an alpha-diketone MITSUBISHI RAYON COMPANY LIMITED (JP) 1991-09-10 US disclosed
EP-0201903-B1 PHOTOPOLYMERIZABLE COMPOSITION MITSUBISHI RAYON CO., LTD. (JP) 1991-08-07 EP disclosed
US-4826888-A STORAGE STABLE, DISCOLORATION INHIBITION MITSUBISHI RAYON CO., LTD. (JP) 1989-05-02 US disclosed
US-4777190-A Photopolymerizable composition based on a vinyl compound, a sulfur-containing compound and an α-diketone MITSUBISHI RAYON COMPANY LIMITED (JP) 1988-10-11 US disclosed
EP-0201903-A2 Photopolymerizable composition MITSUBISHI RAYON CO., LTD. (JP) 1986-11-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10894775-B2 Piperidine derivatives as liver X receptor beta agonists, compositions, and their use NR1H2, NR1H3, ADRB1 TSHR 525/4885CASP1 2530/4885SMN1; SMN2 3587/4885
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING SHH, GLI1, SMO TSHR 421/4885CASP1 2749/4885SMN1; SMN2 4094/4885
US-20240116872-A1 PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING SHH, GLI1, SMO TSHR 453/4885CASP1 2694/4885SMN1; SMN2 4106/4885
US-20210070707-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING SHH, GLI1, SMO TSHR 421/4885CASP1 2749/4885SMN1; SMN2 4094/4885
US-20060063779-A1 Pyridyl inhibitors of hedgehog signalling SHH, GLI1, SMO TSHR 421/4885CASP1 2749/4885SMN1; SMN2 4094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.